Your browser doesn't support javascript.
loading
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.
McCormack, Sheena; Dunn, David T; Desai, Monica; Dolling, David I; Gafos, Mitzy; Gilson, Richard; Sullivan, Ann K; Clarke, Amanda; Reeves, Iain; Schembri, Gabriel; Mackie, Nicola; Bowman, Christine; Lacey, Charles J; Apea, Vanessa; Brady, Michael; Fox, Julie; Taylor, Stephen; Antonucci, Simone; Khoo, Saye H; Rooney, James; Nardone, Anthony; Fisher, Martin; McOwan, Alan; Phillips, Andrew N; Johnson, Anne M; Gazzard, Brian; Gill, Owen N.
Afiliación
  • McCormack S; MRC Clinical Trials Unit at UCL, London, UK; 56 Dean Street, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK. Electronic address: s.mccormack@ucl.ac.uk.
  • Dunn DT; MRC Clinical Trials Unit at UCL, London, UK.
  • Desai M; MRC Clinical Trials Unit at UCL, London, UK; HIV & STI Department, Public Health England Centre for Infectious Disease Surveillance and Control, London, UK.
  • Dolling DI; MRC Clinical Trials Unit at UCL, London, UK.
  • Gafos M; MRC Clinical Trials Unit at UCL, London, UK.
  • Gilson R; The Mortimer Market Centre, Central and North West London NHS Foundation Trust, London, UK; Research Department of Infection and Population Health, University College London, London, UK.
  • Sullivan AK; St Stephen's Centre, Chelsea and Westminster Healthcare NHS Foundation Trust, London, UK.
  • Clarke A; Claude Nicol Centre, Royal Sussex County Hospital, Brighton & Sussex University Hospitals NHS Trust, Brighton, UK.
  • Reeves I; Homerton University Hospital NHS Foundation Trust, London, UK.
  • Schembri G; Manchester Centre for Sexual Health, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
  • Mackie N; St Mary's Hospital, Imperial College Healthcare NHS Foundation Trust, London, UK.
  • Bowman C; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Lacey CJ; York Teaching Hospital and Hull York Medical School, University of York, York, UK.
  • Apea V; Ambrose King Centre and Barts Sexual Health Centre, Barts Health NHS Trust, London, UK.
  • Brady M; King's College Hospital NHS Foundation Trust, London, UK.
  • Fox J; Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Taylor S; Birmingham Heartlands Hospital, Heart of England NHS Foundation Trust, Birmingham, UK.
  • Antonucci S; 56 Dean Street, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
  • Khoo SH; University of Liverpool, Liverpool, UK.
  • Rooney J; Gilead Sciences Foster City, CA, USA.
  • Nardone A; HIV & STI Department, Public Health England Centre for Infectious Disease Surveillance and Control, London, UK.
  • Fisher M; Claude Nicol Centre, Royal Sussex County Hospital, Brighton & Sussex University Hospitals NHS Trust, Brighton, UK.
  • McOwan A; 56 Dean Street, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
  • Phillips AN; Research Department of Infection and Population Health, University College London, London, UK.
  • Johnson AM; Research Department of Infection and Population Health, University College London, London, UK.
  • Gazzard B; St Stephen's Centre, Chelsea and Westminster Healthcare NHS Foundation Trust, London, UK.
  • Gill ON; HIV & STI Department, Public Health England Centre for Infectious Disease Surveillance and Control, London, UK.
Lancet ; 387(10013): 53-60, 2016 Jan 02.
Article en En | MEDLINE | ID: mdl-26364263

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Fármacos Anti-VIH / Sexo Inseguro / Profilaxis Pre-Exposición / Combinación Emtricitabina y Fumarato de Tenofovir Disoproxil Tipo de estudio: Clinical_trials Límite: Adult / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Lancet Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Fármacos Anti-VIH / Sexo Inseguro / Profilaxis Pre-Exposición / Combinación Emtricitabina y Fumarato de Tenofovir Disoproxil Tipo de estudio: Clinical_trials Límite: Adult / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Lancet Año: 2016 Tipo del documento: Article